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Background: Cervical disc disease is a common and occasionally disabling condition, occurring 
as a natural consequence of aging in the vast majority of the adult population. Percutaneous 
epidural neuroplasty (PEN) has been used to deliver highly concentrated drugs for chronic neck 
pain and to prevent scarring in cases refractory to conventional epidural blocks. However, the 
clinical course after PEN in cervical disc disease is not well-documented.
Objective: The purpose of this study was to evaluate the efficacy of cervical PEN for single-level 
cervical disc disease.
Study Design: A retrospective observational study.
Methods: A consecutive series of 100 patients who underwent cervical PEN for single-level disc 
disease (bulging or protrusion) were included in this study. Preoperatively, all patients underwent 
magnetic resonance imaging (MRI), and visual analog scale (VAS) scores as well as Odom’s criteria 
were measured preoperatively and at post-operative follow-up visits (one, 3, 6, and 12 months). 
Limitations: The results of this study are limited by the lack of a control group that did not 
undergo treatment with PEN.
Results: Additional block therapy was performed in 58 patients (58.0%). Subsequent surgery 
was performed in 10 patients (10.0%, excluded from data of clinical follow-up). Mean neck pain 
and VAS arm pain scores for all follow-up patients decreased from 6.82 and 4.74 preoperatively to 
2.18 and 1.87 at 12 months after PEN (P < 0.001). More than 80% and 40% of all patients with 
and without additional block therapy after cervical PEN, respectively, showed good and excellent 
outcomes according to Odom’s Criteria during 12 months of follow-up. During this follow-up 
period, no severe complications related to the procedure were observed.
Conclusion: Cervical PEN was shown to be a safe and effective treatment for neck and arm pain 
in single-level disc disease during 12 months of follow-up. 
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Neck pain is usually caused by well-known etiologies such as cervical intervertebral disc, cervical facet joints, atlanto-axial and 
atlanto-occipital joints, ligaments, fascia, muscles, and 
nerve root dura which are capable of transmitting 
pain (1-12). Cervical radicular pain can be caused by 
mechanical compression, nerve root irritation, and/
or neurotoxicity (13). In addition, chronic edema 
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ings, clinical signs of spinal cord compression, symptoms 
of myelopathy, facet joint pain, instability, traumatic 
injuries, bleeding tendency, psychiatric disease, under-
lying systemic disease (except hypertension, diabetes, 
tuberculosis, and hepatitis), and medical history of prior 
spinal surgery.
Clinical Evaluation
All patients were asked to assess their disability 
using a visual analogue scale (VAS; 0–10) for neck pain 
(VAS neck) and arm pain (VAS arm), as well as Odom’s 
Criteria (outcome rating as excellent, good, fair, or 
poor) (44) in order to evaluate the clinical effective-
ness of PEN in terms of pain reduction and functional 
improvement. All patients were instructed to answer 
based on the average severity of their symptoms over 
the week before their visit. Successful pain relief was 
described as good or excellent using Odom’s Criteria. 
The ratings were recorded before the procedure, and 
one, 3, 6, and 12 months after the procedure on an 
outpatient basis by an independent assessor. 
Cervical Percutaneous Epidural Neuroplasty
Cervical PEN was performed similarly to previous 
reports (35,36,38,43). The patients were prepared and 
draped in a sterile manner in a prone position. After 
skin infiltration, an 18-gauge epidural needle (RX epi-
dural needle, Coudé; Epimed International, Johnstown, 
NY) was inserted and advanced to the cervical epidural 
space using the loss of resistance technique at the level 
of C7-T1 interspace toward the midline under fluoros-
copy. Once placement of the needle tip in the epidural 
space was confirmed, the tip was rotated cephalad. Epi-
durography was performed to confirm needle position 
in the epidural space. A Racz epidural catheter (VERSA-
KATH®, Epimed International, Inc.) was placed directly 
into the herniated disc level under fluoroscopic control, 
and 0.5–1 mL of contrast media (IOBRIX®, ACCUZEN, 
Seoul, Korea) was injected to check warning contrast 
filling into the intravascular, subarachnoid, or peri-ve-
nous counter spaces. For the best outcome, the optimal 
catheter position was considered to be the junction 
between cervical disc pathology and the ventral side of 
the dorsal nerve roots (Fig. 1) (45). After confirming the 
proper position of the catheter tip, 1,500 units of hyal-
uronidase (HYALOSE®, IKSU Pharmacy Co., Gyonggi-do, 
Korea) suspended in 2 mL of preservative-free normal 
saline and a 5 mL mixture of 0.2% bupivacaine and 5 
mg of triamcinolone was injected. After all procedures 
were completed, a modified one-day procedure proto-
and fibrosis within a nerve root can alter its response 
threshold and increase sensitivity to pain (13). Cervical 
epidural steroid injections (ESI) have been used to treat 
radicular pain from herniated discs, spinal stenosis, 
chemical discs, chronic pain secondary to post-cervical 
surgery syndrome, and chronic neck pain of discogenic 
origin (14-19). However, the evidence for using cervical 
ESI has been a subject of debate. There is support for 
its application in cervical disc hernia tigon or radiculitis, 
as well as the management of axial or discogenic pain, 
spinal stenosis, and post-cervical surgery syndrome 
(14-17,20-34). Recently, cervical percutaneous epidural 
neuroplasty (PEN) was derived from lumbar PEN and 
has been used as a treatment option for cervical disc 
herniation (35-41). PEN is considered more effective than 
ESI, as it provides a more localized, selective block in the 
epidural space and is closer to the dorsal root ganglion 
and ventral aspect of the nerve root, possibly reducing 
the need for additional treatment (42). Previous reports 
have indicated that cervical PEN showed a favorable 
clinical effect in patients unresponsive to conventional 
ESI for cervical degenerative diseases (35,38,43). 
Another study reported that cervical PEN showed 
good clinical outcomes in the treatment of cervical 
disc herniation and could be considered a treatment 
modality for cervical disc herniation refractory to 
conservative treatment (38). However, the clinical 
course after PEN in cervical disc disease was not clearly 
investigated. Therefore, the aim of this study was to 
evaluate the efficacy of cervical PEN in patients with 
single-level cervical disc disease until 12 months follow-
up with clinical course using Odom’s Criteria.
Methods
This retrospective observational study was approved 
by the Institutional Review Board (GTIRB-13-005), and 
written informed consent was obtained from all pa-
tients. Chronic posterior neck and radicular pain was 
diagnosed on the basis of clinical symptoms, neurologi-
cal examination, and imaging studies including plain 
radiography and magnetic resonance imaging (MRI). 
Patients older than 20 years and younger than 80 years 
who had single-level herniated cervical disc, concordant 
with radicular pain demonstrated using MRI, were in-
cluded in the study. Patients were included if they had 
pain lasting more than 3 months, which decreased by 
less than 50% at 4 weeks after conservative therapy and 
cervical pain procedures such as medial branch block 
and/or cervical ESI. Exclusion criteria were as follows: 
discordance between clinical symptoms and MRI find-
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col by Manchikanti et al (46,47) was applied. Patients 
were asked to perform neural flossing exercises to 
break up weakened scar tissue and to prevent further 
scar tissue development (40).
Statistical Analysis
Student’s t-tests and chi-square tests were con-
ducted to estimate the clinical outcomes after cervical 
PEN. All statistical analyses were performed using SPSS 
software (SPSS Inc., Chicago, IL, USA), and statistical 
significance was defined as P < 0.05.
Results
In total, 100 patients (53 men and 47 women) com-
pleted the 12-month follow-up, and the mean age was 
48.8 ± 9.1 years old with a range of 29 to 68 years. The 
mean duration of pre-procedural pain was 26.6 ± 50.6 
months with a range of 4 to 360 weeks. The mean dura-
tion between cervical ESI and cervical PEN was 11.2 ± 4.7 
weeks, and the mean duration between cervical medial 
branch block and cervical PEN was 4.7 ± 2.3 weeks. The 
most frequently involved cervical level was C5/6 (46 pa-
tients) followed by C6/7 (27 patients), C4/5 (19 patients), 
and C3/4 (8 patients) (Table 1). Protruding discs were 
present in 82 patients (82.0%) and 18 patients (18.0%) 
had bulging discs.
Additional block therapy was performed in 58 pa-
tients (58.0%), with use of medial branch block in 37 pa-
tients, cervical ESI in 5 patients, and both of these in 16 
patients. The main cause of additional block therapies 
was remnant central neck pain aggravated by cervical 
facet movement and/or remnant cervical root irritation 
pain until 6 weeks after cervical PEN. Of the 100 pa-
tients, 10 patients (10.0%) with a poor outcome elected 
subsequent surgery during the follow-up period. The 
clinical results of patients who underwent subsequent 
surgery were excluded from the clinical analysis. Mean 
neck pain and arm pain VAS scores for all follow-up 
patients (except the 10 patients who underwent subse-
quent surgery) decreased, respectively, from 6.82 ± 1.65 
and 4.74 ± 2.19 preoperatively to 1.48 ± 2.72 and 1.37 
± 2.13 at one month, 2.11 ± 2.75 and 1.80 ± 2.32 at 3 
months, 2.26 ± 2.56 and 1.71 ± 1.95 at 6 months, and 
2.18 ± 2.40 and 1.87 ± 2.22 at 12 months (Fig. 2 and Fig. 
3). Clinically significant differences were observed for 
all follow-up time points when compared to preopera-
tive scores (P < 0.001) and post-operative one month (P 
< 0.05) scores for VAS neck pain, and at all follow-up 
periods compared to preoperative (P < 0.001) and post-
operative 3 months compared to post-operative one 
Fig. 1. Cervical percutaneous epidural neuroplasty (arrow 
indicates the catheter location).
Number 100
Male Ratio 53 (53.0%)
Mean Age 48.8 ± 9.1
Duration (month) 26.6 ± 50.6
Level
C3/4 8 (8.0%)
C4/5 19 (19.0%)
C5/6 46 (46.0%)
C6/7 27 (27.0%)
Disc Type
Bulging 18 (18.0%)
Protrusion 82 (82.0%)
HTN 21 (21.0%)
DM 28 (28.0%)
Tuberculosis 3 (3.0%)
Hepatitis 4 (4.4%)
Table 1. Demographic data of  all the patients.
month (P = 0.025) for VAS neck pain. No statistical dif-
ferences were observed when comparing VAS neck and 
arm pain at post-operative 6 months.
Patient satisfaction at 12 months post-procedure 
was measured using Odom’s Criteria, excluding pa-
tients who underwent subsequent surgery (Fig. 4). 
Odom’s Criteria at post-operative one month ranked 
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Fig. 2. Total mean VAS scores for neck pain after percutaneous epidural neuroplasty were significantly lower than preoperative 
scores. (All follow-up VAS scores had a statistical difference of  less than 0.001 when compared to pre-neuroplasty VAS scores.)
Fig. 3. Total mean VAS scores for arm pain after percutaneous epidural neuroplasty were significantly lower than preoperative 
scores. (All follow-up VAS scores have a statistical difference of  less than 0.001 when compared to pre-neuroplasty VAS scores.)
63 patients (70.0%) as excellent, 16 patients (17.8%) 
as good, and 11 patients (12.2%) as fair. By 3 months 
follow-up, 12 patients changed from excellent to good, 
5 patients from excellent to fair, 9 patients from good 
to excellent, 4 patients from good to fair, 5 patients 
from fair to good, and one patient from fair to poor. 
Therefore, at post-operative 3 months, outcomes were 
ranked as excellent in 55 patients (61.1%), good in 
20 patients (22.2%), fair in 14 patients (15.6%), and 
fair in one patient (1.1%). By 6 months follow-up, 6 
patients changed from excellent to good, 4 patients 
from excellent to fair, one patient from excellent to 
poor, 7 patients from good to excellent, 5 patients from 
good to fair, 11 patients from fair to good, one patient 
from fair to poor, and one patient from poor to good. 
Therefore, at post-operative 6 months, outcomes were 
ranked as excellent in 51 patients (56.7%), good in 26 
patients (28.8%), fair in 11 patients (12.2%), and fair 
in 2 patients (2.2%). Finally, by 12 months follow-up, 
8 patients changed from excellent to good, 2 patients 
from excellent to fair, 3 patients from excellent to poor, 
7 patients from good to excellent, 4 patients from good 
to fair, 2 patients from fair to excellent, 7 patient from 
fair to good, and one patient from poor to good. At 
the final assessment using Odom’s Criteria at post-
operative 12 months, outcomes were excellent in 47 
patients (52.2%), good in 31 patients (34.5%), fair in 8 
patients (8.9%), and fair in 4 patients (4.4%). Including 
patients with subsequent surgery, the final distribution 
of positive outcomes according to Odom’s Criteria (ex-
cellent and good) were observed in 78 patients (86.7% 
among 90 patients and 78.0% among 100 patients). 
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Additionally, cervical PEN provided excellent outcomes 
in 42.0% of patients (of 100) without additional block 
therapy. Patients with excellent outcomes received ad-
ditional block therapy during the 12 month follow-up 
period (83.0%, 39 among 47 patients), including medial 
branch block (34 patients), cervical ESI (one patient), 
and both types of block (4 patients). No serious com-
plications occurred in this series during the 12 month 
follow-up period.
discussion
Local anesthetic mixed with corticosteroid may 
have additional benefits beyond the direct anes-
thetic affects. Lidocaine has been shown to have an 
anti-inflammatory effect on nucleus pulposus-induced 
nerve injury (48,49). The rationale for corticosteroid 
instillation also includes an anti-inflammatory effect. 
Cervical herniated disk specimens have demonstrated 
increased levels of phospholipase A2, which plays a role 
in inflammation of the nerve root and may be neuro-
toxic. However, epidural steroids have been shown to 
inhibit phospholipase A2 activity and reduce symptoms 
(50-53). With increased delivery of these substances to 
the localized epidural space (closer to the dorsal root 
ganglion and ventral aspect of the nerve root), cervi-
cal PEN showed good clinical results compared to ESI 
(45). The indication for cervical PEN is broad, including 
cervicalgia or cervical radiculopathy with any of the fol-
lowing origins: failed neck surgery syndrome, cervical 
disc bulge with or without cervical radiculopathy, cervi-
cal radiculopathy, epidural fibrosis, and spinal stenosis 
(36). Further, clinical studies examining cervical PEN are 
sparse. In the literature, 4 reports indicated that cervi-
cal PEN had favorable clinical effects for patients with 
cervical disc herniation and/or central stenosis who did 
not respond to fluoroscopically guided epidural injec-
tions (35,38,43,45). 
A prospective study by Park et al (43) detailed the 
performance of cervical PEN in 39 patients with central 
cervical stenosis. All patients had a reinforced navigable 
catheter inserted at T1-2 advanced cephalad and then 
received an initial solution which contained local anes-
thetic, hyaluronidase, and corticosteroid. The follow-up 
periods were at 2 weeks and 6 months, and the outcome 
measure was a Roland 5-point patient satisfaction scale 
(0 indicated no pain and 5 indicated unbearable pain). 
Three patients (7.7%) elected to have spinal surgery 
during the follow-up period. Pain improvement was 
demonstrated in 30 of 39 patients (77.0%) at 2 weeks 
and in 28 of 39 patients (71.8 %) at 6 months. However, 
this exploratory study did not report baseline data, so it 
is difficult to interpret the follow-up data (39).
A retrospective study by Park et al (35) evaluated 
the outcome of cervical PEN in 128 patients with cervi-
cal disc herniation. Patients with refractory radicular 
pain were included in the study, but patients with a 
prior history of surgery were excluded. Radiopaque 
epidural catheters were placed at C7-T1 or T1-T2 in all 
patients, and advanced cephalad to the level of disc 
herniation. Adhesiolysis using hyaluronidase solution 
was performed, followed by delivery of ropivacaine 
with dexamethasone. Follow-up was performed at 
one day, and one, 3, 6, and 12 months post-treatment. 
Twelve patients received cervical ESI one month after 
adhesiolysis due to remnant pain. Five patients (3.9%) 
elected to have spinal surgery during the follow-up 
period. Overall, the numeric rating scale results showed 
significant improvement at all time points for arm (from 
Fig. 4. The 
overall success 
rates according to 
Odom’s Criteria 
(excluding 
patients with 
subsequent 
surgery during 
the 12 months 
after PEN 
treatment).
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73.0 at baseline to 8.3 at 12 months) and neck pain 
(from 77.0 at baseline to 4.1 at 12 months). Mean neck 
disability scores also decreased from a baseline of 17.5 
to 2.3 at 12 months follow-up. No serious complications 
were reported. Although the evidence is weak, this 
study suggests that some patients with spinal stenosis 
and disc herniation who failed conservative therapy 
might benefit from cervical PEN.
An observational study by Moon et al (38) evaluat-
ed the clinical outcomes of cervical PEN in 169 patients 
with posterior neck and upper extremity pain and the 
predictive factors for unsuccessful cervical PEN results. 
An epidural catheter was placed at T1-T2, and then ad-
vanced and maneuvered into the target disc herniation 
lesion. Hyaluronidase in preservative-free normal saline 
was injected via epidural catheter, and subsequently 
a mixture of bupivacaine and triamcinolone was in-
jected. Follow-up visits were performed through 12 
months post-treatment. Three patients (1.8%) elected 
to have spinal surgery during the follow-up period. 
Successful outcomes (50% or greater reduction on 
total pain rating scale compared to the pre-procedure 
value, and at least a 40% reduction on the neck pain 
and disability scale) were observed in 108 patients 
(63.9%) at one month following the procedure, in 109 
patients (64.5%) at 3 months, in 96 patients (56.8%) 
at 6 months, and in 89 patients (52.7%) at 12 months. 
Previous surgery, spondylolisthesis, and ossification of 
the posterior longitudinal ligament were significantly 
associated with unsuccessful outcomes (P < 0.05). There 
were no adverse events except for transient local pain 
associated with the procedure. Although the lack of a 
placebo group was one of the limitations, this study 
suggested that cervical PEN may be an effective treat-
ment for pain reduction and functional improvement in 
patients with cervical spinal pain who did not respond 
to conservative treatment, possibly decreasing surgical 
demand.
A randomized control study by Ji et al (45) com-
pared the clinical efficacy of cervical PEN and cervical 
ESI. Eighty patients with neck pain from single-level 
cervical disease with and without radiculopathy were 
included. Patients were randomly assigned into 2 
groups: cervical PEN or ESI. Both the cervical PEN and 
ESI groups showed a better neck disability index (NDI) 
recovery and a greater reduction in VAS score at post-
operative 6 months (P < 0.001). The cervical PEN group 
demonstrated a better NDI score at post-operative 6 
months than the ESI group (P = 0.014), while there were 
no differences at 2, 4, and 12 months. The cervical PEN 
group showed lower VAS scores at all follow-up time 
points compared to the ESI group (P < 0.050). Symptom 
relief was sustained for a significantly longer duration 
in the cervical PEN group than in the ESI group (23.4 vs. 
20.5 weeks, P < 0.001). Therefore, the investigators con-
cluded that cervical PEN was superior to ESI in terms of 
better NDI recovery (at 6 months) and greater reduction 
in VAS score (until 12 months) for treating single-level 
cervical disc herniation. They also reported that better 
outcomes with cervical PEN may have been achieved via 
a more localized, selective block in the epidural space 
closer to the dorsal root ganglion and ventral aspect of 
the nerve root.
Similar to 4 previous studies (35,38,43,45), this 
study evaluated the clinical course and effectiveness of 
cervical PEN in single-level cervical disc disease. A total 
of 100 patients with single-level herniated cervical disc 
with concordant radicular pain demonstrated by MRI 
were included in the study. A Racz catheter was ad-
vanced through C7-T1, and the catheter tip was placed 
in the target disc herniation lesion. Hyaluronidase with 
preservative-free normal saline and a mixture of bupi-
vacaine and triamcinolone were subsequently injected. 
The hyaluronidase (HYALOSE®) used in this study was 
a powder, so additional volume was not added to 
cocktails. Follow-up visits were performed at one, 3, 6, 
and 12 months after cervical PEN. Fifty-eight patients 
received additional block therapy during the follow-up 
period after adhesiolysis due to remnant pain. Com-
pared to previous studies, a relatively high proportion 
of patients (n = 10, 10.0% vs. 1.8~7.7%) elected to 
have spinal surgery within one month after the op-
eration. There were significant decreases in mean VAS 
for neck pain (from 6.82 at preoperative to 2.18 at 12 
months) and arm pain scores (from 4.74 to 1.87 at 12 
months) at all follow-up time points. Indeed, during 12 
months, more than 80% of all patients who underwent 
PEN showed good and excellent outcomes according 
to Odom’s Criteria. Clinical results in recent studies 
showed better outcomes compared to the previous 3 
studies, although different clinical methods were ap-
plied. We propose that these favorable results might be 
derived from the additional block treatments (medial 
branch block and/or cervical ESI) which were performed 
in 58 patients (58.0%) during follow-up. The additional 
treatment may have also interfered with the clinical 
course after cervical PEN: the outcome of 50 patients 
increased according to Odom’s Criteria, such as good to 
excellent and fair to good. There were no severe com-
plications related to the procedure. This study suggests 
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that cervical PEN is a safe and effective treatment for 
neck and arm pain in single-level disc disease, similar to 
the results of 4 previous studies (35,38,43,45).
The PEN procedure is considered to be more effec-
tive than ESI as it comprises a more localized, selective 
block in the epidural space placed closer to the dorsal 
root ganglion and ventral aspect of the nerve root, be-
tween the nerve and the disc herniated particle where 
micro-adhesion by the inflamed nerve is suspected (45). 
If micro adhesion by discal irritation with an inflamed 
nerve is present, this micro-adhesion could be removed 
by mechanical adhesiolysis (catheter indwelling), chem-
ical adhesiolysis (hyaluronidase), and hydrostatic adhe-
siolysis (radio-opaque dye and saline) as the authors 
previously reported (45). The more favorable results 
for cervical PEN are believed to be a result of a more 
localized, selective block in the epidural space placed 
closer to the dorsal root ganglion and ventral aspect 
of the nerve root compared to ESI. By greater selective 
targeting of lesions, symptom relief was maintained for 
a longer duration using the cervical PEN treatment.
There were several limitations to this study. First, 
there was no control group. Secondly, this study in-
cluded patients with single-level disc disease and data 
were categorized according to a simple classifier (bulg-
ing and protrusion). In spite of these limitations, we 
reported the efficacy of cervical PEN among single-level 
cervical disc disease patients. This study suggests that 
cervical PEN can be used as another treatment strategy 
for patients with cervical disc disease. Large-scale, ran-
domized controlled studies with longer follow-up dura-
tions are required to examine the effects of cervical PEN 
in patients with cervical disc degeneration.
conclusion
This study evaluated the clinical course of cervical 
PEN and showed that the procedure is a safe and ef-
fective treatment for single-level disc disease up to 12 
months of follow-up. Cervical PEN should be considered 
as a next-step treatment modality for treating single-
level disc disease refractory to conservative treatment.
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